This review summarizes the pharmacokinetics, pharmacodynamics, and clinical application of dihydropyridine calcium antagonists in cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
Provides a consolidated reference on dihydropyridine calcium antagonists; leaves open gaps for updated trials in specific populations.
This article contains information concerning the aspects of pharmacokinetics and pharmacodynamics of dihydropyridine calcium antagonists. The authors have discussed the evidence-based amlodipine treatment of arterial hypertension, ischemic heart disease and chronic heart failure. The authors present the comparison of the efficacy, safety and application characteristics of the different dihydropyridine calcium antagonists that can be used in specific clinical cases.
No takes yet. Share an insight, caveat, or question.
O.D. et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: